Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer
Clinical trial NCT03924882 · UNKNOWN
Trial details
- NCT number
- NCT03924882
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-25
- Primary completion
- 2021-04-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.